MAP Kinase Phosphatase 3 (MKP3) Preserves Norepinephrine Transporter Activity by Modulating ERK1/2 Kinase-Mediated Gene Expression

The norepinephrine transporter (NET) mediates the clearance of norepinephrine (NE) from the extracellular space and is a target of therapeutic antidepressants and psychostimulants. Previously we identified a MAP kinase phosphatase 3 (MKP3), as an important modulator of protein kinase C (PKC) mediate...

Full description

Bibliographic Details
Main Authors: Ole V. Mortensen, Mads B. Larsen, Susan G. Amara
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-08-01
Series:Frontiers in Cellular Neuroscience
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fncel.2017.00253/full
_version_ 1818177257552740352
author Ole V. Mortensen
Mads B. Larsen
Susan G. Amara
author_facet Ole V. Mortensen
Mads B. Larsen
Susan G. Amara
author_sort Ole V. Mortensen
collection DOAJ
description The norepinephrine transporter (NET) mediates the clearance of norepinephrine (NE) from the extracellular space and is a target of therapeutic antidepressants and psychostimulants. Previously we identified a MAP kinase phosphatase 3 (MKP3), as an important modulator of protein kinase C (PKC) mediated internalization of the related dopamine transporter (DAT). Here we show that MKP3 decreases PKC-mediated down regulation of NET expressed in PC12 cells. We demonstrate that this process involves a PKC-stimulated decrease of NET surface expression that is dependent on dynamin. Surprisingly, MAP kinase inhibitors have no effect on the PKC-mediated regulation of NET activity, suggesting that, like PKC-mediated regulation of the DAT, the acute activation of MAP kinases is not likely to be involved. To elucidate potential mechanisms we used a substrate trap-based assay to identify extracellular-signal-regulated kinase (ERK)1/2 as the predominant substrate of MKP3. Furthermore we also established that brief chemical stabilization of a modified destabilized MKP3 does not alter PKC-mediated down regulation of NET. Finally, the expression of a dominant negative version of H-Ras, an upstream activator of ERK1/2, abolishes phorbol 12-myristate 13-acetate (PMA)-mediated down regulation of NET in a manner similar to MKP3. Taken together we propose that chronic MKP3 expression regulates surface NET through the sustained inhibition of ERK1/2 MAP kinase signaling that alters gene expression in PC12 cells. This is supported by gene expression data from naïve and MKP3-expressing PC12 cells that reveal robust decreases in gene expression of several genes in the MKP3-tranfected cells. Interestingly, caveolin-1, a protein with a critical role in membrane protein trafficking is down regulated by MKP3 expression. We further show that selective silencing of the caveolin-1 gene in naïve PC12 cells attenuates PKC-mediated downregulation of NET activity, consistent with a potential role for caveolins in regulating NET surface expression. In summary, these results suggest that chronic MKP3 expression alters the expression of genes in PC12 cells that are involved in the regulation of NET surface expression.
first_indexed 2024-12-11T20:29:13Z
format Article
id doaj.art-be7642daeb06480d9d3ba028a33891ea
institution Directory Open Access Journal
issn 1662-5102
language English
last_indexed 2024-12-11T20:29:13Z
publishDate 2017-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular Neuroscience
spelling doaj.art-be7642daeb06480d9d3ba028a33891ea2022-12-22T00:51:52ZengFrontiers Media S.A.Frontiers in Cellular Neuroscience1662-51022017-08-011110.3389/fncel.2017.00253286269MAP Kinase Phosphatase 3 (MKP3) Preserves Norepinephrine Transporter Activity by Modulating ERK1/2 Kinase-Mediated Gene ExpressionOle V. Mortensen0Mads B. Larsen1Susan G. Amara2Department of Pharmacology and Physiology, Drexel University College of MedicinePhiladelphia, PA, United StatesDepartment of Cell Biology and Physiology, University of Pittsburgh School of MedicinePittsburgh, PA, United StatesNational Institute of Mental HealthBethesda, MD, United StatesThe norepinephrine transporter (NET) mediates the clearance of norepinephrine (NE) from the extracellular space and is a target of therapeutic antidepressants and psychostimulants. Previously we identified a MAP kinase phosphatase 3 (MKP3), as an important modulator of protein kinase C (PKC) mediated internalization of the related dopamine transporter (DAT). Here we show that MKP3 decreases PKC-mediated down regulation of NET expressed in PC12 cells. We demonstrate that this process involves a PKC-stimulated decrease of NET surface expression that is dependent on dynamin. Surprisingly, MAP kinase inhibitors have no effect on the PKC-mediated regulation of NET activity, suggesting that, like PKC-mediated regulation of the DAT, the acute activation of MAP kinases is not likely to be involved. To elucidate potential mechanisms we used a substrate trap-based assay to identify extracellular-signal-regulated kinase (ERK)1/2 as the predominant substrate of MKP3. Furthermore we also established that brief chemical stabilization of a modified destabilized MKP3 does not alter PKC-mediated down regulation of NET. Finally, the expression of a dominant negative version of H-Ras, an upstream activator of ERK1/2, abolishes phorbol 12-myristate 13-acetate (PMA)-mediated down regulation of NET in a manner similar to MKP3. Taken together we propose that chronic MKP3 expression regulates surface NET through the sustained inhibition of ERK1/2 MAP kinase signaling that alters gene expression in PC12 cells. This is supported by gene expression data from naïve and MKP3-expressing PC12 cells that reveal robust decreases in gene expression of several genes in the MKP3-tranfected cells. Interestingly, caveolin-1, a protein with a critical role in membrane protein trafficking is down regulated by MKP3 expression. We further show that selective silencing of the caveolin-1 gene in naïve PC12 cells attenuates PKC-mediated downregulation of NET activity, consistent with a potential role for caveolins in regulating NET surface expression. In summary, these results suggest that chronic MKP3 expression alters the expression of genes in PC12 cells that are involved in the regulation of NET surface expression.http://journal.frontiersin.org/article/10.3389/fncel.2017.00253/fullcaveolindual-specificity phosphoprotein phosphataseextracellular-signal-regulated kinase (ERK)mitogen-activated protein kinase (MAPK)monoamine transporternorepinephrine
spellingShingle Ole V. Mortensen
Mads B. Larsen
Susan G. Amara
MAP Kinase Phosphatase 3 (MKP3) Preserves Norepinephrine Transporter Activity by Modulating ERK1/2 Kinase-Mediated Gene Expression
Frontiers in Cellular Neuroscience
caveolin
dual-specificity phosphoprotein phosphatase
extracellular-signal-regulated kinase (ERK)
mitogen-activated protein kinase (MAPK)
monoamine transporter
norepinephrine
title MAP Kinase Phosphatase 3 (MKP3) Preserves Norepinephrine Transporter Activity by Modulating ERK1/2 Kinase-Mediated Gene Expression
title_full MAP Kinase Phosphatase 3 (MKP3) Preserves Norepinephrine Transporter Activity by Modulating ERK1/2 Kinase-Mediated Gene Expression
title_fullStr MAP Kinase Phosphatase 3 (MKP3) Preserves Norepinephrine Transporter Activity by Modulating ERK1/2 Kinase-Mediated Gene Expression
title_full_unstemmed MAP Kinase Phosphatase 3 (MKP3) Preserves Norepinephrine Transporter Activity by Modulating ERK1/2 Kinase-Mediated Gene Expression
title_short MAP Kinase Phosphatase 3 (MKP3) Preserves Norepinephrine Transporter Activity by Modulating ERK1/2 Kinase-Mediated Gene Expression
title_sort map kinase phosphatase 3 mkp3 preserves norepinephrine transporter activity by modulating erk1 2 kinase mediated gene expression
topic caveolin
dual-specificity phosphoprotein phosphatase
extracellular-signal-regulated kinase (ERK)
mitogen-activated protein kinase (MAPK)
monoamine transporter
norepinephrine
url http://journal.frontiersin.org/article/10.3389/fncel.2017.00253/full
work_keys_str_mv AT olevmortensen mapkinasephosphatase3mkp3preservesnorepinephrinetransporteractivitybymodulatingerk12kinasemediatedgeneexpression
AT madsblarsen mapkinasephosphatase3mkp3preservesnorepinephrinetransporteractivitybymodulatingerk12kinasemediatedgeneexpression
AT susangamara mapkinasephosphatase3mkp3preservesnorepinephrinetransporteractivitybymodulatingerk12kinasemediatedgeneexpression